153 related articles for article (PubMed ID: 26545488)
1. A comparative study of proliferative activity and tumor stage of pregnancy-associated melanoma (PAM) and non-PAM in gestational age women.
Merkel EA; Martini MC; Amin SM; Yélamos O; Lee CY; Sholl LM; Rademaker AW; Guitart J; Gerami P
J Am Acad Dermatol; 2016 Jan; 74(1):88-93. PubMed ID: 26545488
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and outcomes of cutaneous melanoma in women less than 50 years of age.
Tellez A; Rueda S; Conic RZ; Powers K; Galdyn I; Mesinkovska NA; Gastman B
J Am Acad Dermatol; 2016 Apr; 74(4):731-8. PubMed ID: 26803345
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma in pregnancy. A population-based evaluation.
O'Meara AT; Cress R; Xing G; Danielsen B; Smith LH
Cancer; 2005 Mar; 103(6):1217-26. PubMed ID: 15712209
[TBL] [Abstract][Full Text] [Related]
4. Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.
Vihinen P; Vainio-Kaila M; Talve L; Koskivuo I; Syrjänen K; Pyrhönen S
Acta Oncol; 2012 May; 51(5):662-8. PubMed ID: 22486294
[TBL] [Abstract][Full Text] [Related]
5. Is Pregnancy-Associated Melanoma Associated with Adverse Outcomes?
Jones MS; Lee J; Stern SL; Faries MB
J Am Coll Surg; 2017 Jul; 225(1):149-158. PubMed ID: 28457692
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and early-stage melanoma.
Daryanani D; Plukker JT; De Hullu JA; Kuiper H; Nap RE; Hoekstra HJ
Cancer; 2003 May; 97(9):2248-53. PubMed ID: 12712479
[TBL] [Abstract][Full Text] [Related]
7. A single-institution assessment of superficial spreading melanoma (SSM) in the pediatric population: Molecular and histopathologic features compared with adult SSM.
Verzì AE; Bubley JA; Haugh AM; Zhang B; Wagner A; Kruse L; West DP; Wayne J; Guitart J; Gerami P
J Am Acad Dermatol; 2017 Nov; 77(5):886-892. PubMed ID: 28754310
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy and melanoma.
Driscoll MS; Martires K; Bieber AK; Pomeranz MK; Grant-Kels JM; Stein JA
J Am Acad Dermatol; 2016 Oct; 75(4):669-678. PubMed ID: 27646737
[TBL] [Abstract][Full Text] [Related]
9. Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.
Nielsen PS; Riber-Hansen R; Jensen TO; Schmidt H; Steiniche T
Mod Pathol; 2013 Mar; 26(3):404-13. PubMed ID: 23174936
[TBL] [Abstract][Full Text] [Related]
10. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.
Tetzlaff MT; Curry JL; Ivan D; Wang WL; Torres-Cabala CA; Bassett RL; Valencia KM; McLemore MS; Ross MI; Prieto VG
Mod Pathol; 2013 Sep; 26(9):1153-60. PubMed ID: 23558574
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of pregnancy in stage I melanoma.
Wong JH; Sterns EE; Kopald KH; Nizze JA; Morton DL
Arch Surg; 1989 Oct; 124(10):1227-30; discussion 1230-1. PubMed ID: 2802988
[TBL] [Abstract][Full Text] [Related]
12. Pediatric melanomas often mimic benign skin lesions: A retrospective study.
Mitkov M; Chrest M; Diehl NN; Heckman MG; Tollefson M; Jambusaria-Pahlajani A
J Am Acad Dermatol; 2016 Oct; 75(4):706-711.e4. PubMed ID: 27430613
[TBL] [Abstract][Full Text] [Related]
13. Incidence and outcomes of pregnancy-associated melanoma in New South Wales 1994-2008.
Bannister-Tyrrell M; Roberts CL; Hasovits C; Nippita T; Ford JB
Aust N Z J Obstet Gynaecol; 2015 Apr; 55(2):116-22. PubMed ID: 25349945
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous melanoma during pregnancy at the Cancer Center-Institute in Warsaw].
Nowecki ZI; Rutkowski P; Lindner B; Ruka W
Ginekol Pol; 2003 Jul; 74(7):525-32. PubMed ID: 14531324
[TBL] [Abstract][Full Text] [Related]
15. Malignant melanoma and pregnancy.
Silipo V; De Simone P; Mariani G; Buccini P; Ferrari A; Catricala C
Melanoma Res; 2006 Dec; 16(6):497-500. PubMed ID: 17119450
[TBL] [Abstract][Full Text] [Related]
16. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
17. Biology of desmoplastic melanoma: a case-control comparison with other melanomas.
Livestro DP; Muzikansky A; Kaine EM; Flotte TJ; Sober AJ; Mihm MC; Michaelson JS; Cosimi AB; Tanabe KK
J Clin Oncol; 2005 Sep; 23(27):6739-46. PubMed ID: 16170181
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Analysis of Clinicopathological Characteristics of Pregnancy Associated Melanoma.
Fábián M; Tóth V; Somlai B; Hársing J; Kuroli E; Rencz F; Kuzmanovszki D; Szakonyi J; Tóth B; Kárpáti S
Pathol Oncol Res; 2015 Sep; 21(4):1265-71. PubMed ID: 26177701
[TBL] [Abstract][Full Text] [Related]
19. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.
Murali R; Hughes MT; Fitzgerald P; Thompson JF; Scolyer RA
Ann Surg; 2009 Apr; 249(4):641-7. PubMed ID: 19300224
[TBL] [Abstract][Full Text] [Related]
20. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin.
Talve LA; Collan YU; Ekfors TO
J Cutan Pathol; 1996 Aug; 23(4):335-43. PubMed ID: 8864921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
